Yin Sun

5.5k total citations
116 papers, 4.2k citations indexed

About

Yin Sun is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yin Sun has authored 116 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 39 papers in Cancer Research and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yin Sun's work include Cancer-related molecular mechanisms research (23 papers), Prostate Cancer Treatment and Research (20 papers) and Ubiquitin and proteasome pathways (16 papers). Yin Sun is often cited by papers focused on Cancer-related molecular mechanisms research (23 papers), Prostate Cancer Treatment and Research (20 papers) and Ubiquitin and proteasome pathways (16 papers). Yin Sun collaborates with scholars based in China, United States and Taiwan. Yin Sun's co-authors include Chawnshang Chang, Xuedong Liu, Harvey F. Lodish, Robert A. Weinberg, Shuyuan Yeh, Stefan N. Constantinescu, Gonghui Li, Jiaoti Huang, Kefeng Wang and Hui Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yin Sun

115 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yin Sun China 35 3.1k 1.6k 758 724 296 116 4.2k
Lili Jiang China 38 2.4k 0.8× 1.2k 0.8× 1.0k 1.4× 607 0.8× 338 1.1× 104 3.5k
Rongcheng Luo China 35 2.4k 0.8× 1.3k 0.8× 1.1k 1.4× 686 0.9× 502 1.7× 207 4.2k
Yujuan Dong China 32 2.9k 0.9× 1.9k 1.2× 670 0.9× 327 0.5× 209 0.7× 48 3.7k
Limin Xia China 39 2.8k 0.9× 1.4k 0.9× 1.0k 1.3× 512 0.7× 594 2.0× 142 4.1k
Lu Yang China 32 2.7k 0.9× 1.7k 1.1× 777 1.0× 364 0.5× 273 0.9× 89 3.7k
Zhao-Lei Zeng China 39 3.5k 1.1× 2.6k 1.7× 1.1k 1.4× 611 0.8× 407 1.4× 90 4.9k
Desheng Xiao China 29 3.2k 1.0× 2.3k 1.4× 651 0.9× 1.8k 2.4× 268 0.9× 116 4.4k
Guoguang Ying China 36 4.0k 1.3× 2.7k 1.7× 759 1.0× 692 1.0× 590 2.0× 88 5.1k

Countries citing papers authored by Yin Sun

Since Specialization
Citations

This map shows the geographic impact of Yin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yin Sun more than expected).

Fields of papers citing papers by Yin Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yin Sun. The network helps show where Yin Sun may publish in the future.

Co-authorship network of co-authors of Yin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yin Sun. A scholar is included among the top collaborators of Yin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yin Sun. Yin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yin, et al.. (2025). The Analysis of Emotion-Aware Personalized Recommendations via Multimodal Data Fusion in the Field of Art. Journal of Organizational and End User Computing. 37(1). 1–29. 1 indexed citations
2.
Sun, Yin, Abraham Bayer, Daniel Lee, et al.. (2025). Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis. Circulation Research. 136(5). 473–490. 3 indexed citations
3.
Zhu, Wei, Xinlu Wang, Lianmin Luo, et al.. (2024). miR-148b-5p regulates hypercalciuria and calcium-containing nephrolithiasis. Cellular and Molecular Life Sciences. 81(1). 369–369. 5 indexed citations
4.
Jiang, Wenhao, et al.. (2024). Comparative Review for Enhancing CO2 Capture Efficiency with Mixed Amine Systems and Catalysts. Molecules. 29(19). 4618–4618. 16 indexed citations
5.
Zhu, Wei, Xin Zhang, Yin Sun, et al.. (2023). Predictive value of single-nucleotide polymorphism signature for nephrolithiasis recurrence: a 5-year prospective study. Clinical Kidney Journal. 16(11). 2205–2215.
6.
Guo, Chuanyong, Yin Sun, Wei Zhai, et al.. (2022). Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis. Cell & Bioscience. 12(1). 185–185. 8 indexed citations
7.
Gong, Dongkui, Yin Sun, Chuanyong Guo, et al.. (2021). Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis. SHILAP Revista de lepidopterología. 11(3). 27 indexed citations
8.
Xiang, Zhendong, Yin Sun, Bosen You, et al.. (2021). Suppressing BCL-XL increased the high dose androgens therapeutic effect to better induce the Enzalutamide-resistant prostate cancer autophagic cell death. Cell Death and Disease. 12(1). 68–68. 13 indexed citations
9.
Xiao, Yao, Guodong Liu, Yin Sun, et al.. (2020). Targeting the estrogen receptor alpha (ERα)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion. Oncogene. 39(12). 2493–2508. 33 indexed citations
11.
Han, Zhenwei, Yong Zhang, Yin Sun, et al.. (2018). ERβ-Mediated Alteration of circATP2B1 and miR-204-3p Signaling Promotes Invasion of Clear Cell Renal Cell Carcinoma. Cancer Research. 78(10). 2550–2563. 65 indexed citations
12.
Huang, Qingbo, Yin Sun, Xin Ma, et al.. (2017). Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma. Nature Communications. 8(1). 918–918. 67 indexed citations
13.
Shi, Liang, Hui Lin, Gonghui Li, et al.. (2016). Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression. Molecular Cancer Therapeutics. 15(4). 731–742. 46 indexed citations
15.
Zhu, Jin, Dongrong Yang, Yin Sun, et al.. (2015). TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression. Molecular Cancer Therapeutics. 14(6). 1445–1453. 15 indexed citations
16.
Gan, Wenjian, Xiangpeng Dai, Andrea Lunardi, et al.. (2015). SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression. PMC. 1 indexed citations
17.
Chen, Yuan, et al.. (2015). Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status. Oncotarget. 6(31). 31203–31215. 38 indexed citations
18.
Li, Zhen, Yin Sun, Xufeng Chen, et al.. (2014). p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma. Molecular Cancer Research. 13(3). 584–591. 63 indexed citations
19.
Tai, Sheng, Yin Sun, Nan Liu, et al.. (2012). Combination of Rad001 (Everolimus) and Propachlor Synergistically Induces Apoptosis through Enhanced Autophagy in Prostate Cancer Cells. Molecular Cancer Therapeutics. 11(6). 1320–1331. 24 indexed citations
20.
Liu, Nan, Sheng Tai, Boxiao Ding, et al.. (2012). Arsenic trioxide synergizes with everolimus (Rad001) to induce cytotoxicity of ovarian cancer cells through increased autophagy and apoptosis. Endocrine Related Cancer. 19(5). 711–723. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026